<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">8804070</journal-id><journal-id journal-id-type="pubmed-jr-id">3570</journal-id><journal-id journal-id-type="nlm-ta">Eur J Clin Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Clin Nutr</journal-id><journal-title-group><journal-title>European journal of clinical nutrition</journal-title></journal-title-group><issn pub-type="ppub">0954-3007</issn><issn pub-type="epub">1476-5640</issn></journal-meta><article-meta><article-id pub-id-type="pmid">21952692</article-id><article-id pub-id-type="pmc">3252467</article-id><article-id pub-id-type="doi">10.1038/ejcn.2011.159</article-id><article-id pub-id-type="manuscript">NIHMS314569</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cox</surname><given-names>Chad L.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stanhope</surname><given-names>Kimber L.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Schwarz</surname><given-names>Jean Marc</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Graham</surname><given-names>James L.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hatcher</surname><given-names>Bonnie</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Griffen</surname><given-names>Steven C.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bremer</surname><given-names>Andrew A.</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Berglund</surname><given-names>Lars</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>McGahan</surname><given-names>John P.</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Havel</surname><given-names>Peter J.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Keim</surname><given-names>Nancy L.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A7">7</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Nutrition, University of California, Davis, One Shields Ave, Davis, CA, 95616</aff><aff id="A2"><label>2</label>Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, One Shields Avenue, Davis, California 95616</aff><aff id="A3"><label>3</label>Department of Basic Sciences, College of Osteopathic Medicine, Touro University, 1310 Johnson Lane, Mare Island, Vallejo, CA 94592</aff><aff id="A4"><label>4</label>Department of Internal Medicine, UCD School of Medicine, 4610 X St., Sacramento, California 95817</aff><aff id="A5"><label>5</label>Department of Pediatrics, School of Medicine, Vanderbilt University, Nashville, TN 37232</aff><aff id="A6"><label>6</label>Department of Radiology, UCD Medical Center, 2315 Stockton Blvd. Sacramento, California, 95817</aff><aff id="A7"><label>7</label>United States Department of Agriculture, Western Human Nutrition Research Center, 430 W. Health Sciences Dr., Davis, California, 95616</aff><author-notes><corresp id="FN1">Corresponding author and reprint requests: Nancy L. Keim,United States Department of Agriculture, Western Human Nutrition Research Center, 430 W. Health Sciences Dr., Davis, California, 95616, USA Phone: 530-752-4163 Fax: 530-752-5295 <email>Nancy.Keim@ars.usda.gov</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>4</day><month>8</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>28</day><month>9</month><year>2011</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2012</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>8</month><year>2012</year></pub-date><volume>66</volume><issue>2</issue><fpage>201</fpage><lpage>208</lpage><!--elocation-id from pubmed: 10.1038/ejcn.2011.159--><permissions><license><license-p>Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: 
<uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p></license></permissions><abstract><sec id="S1"><title>Background/Objectives</title><p id="P1">The results of short-term studies in humans suggest that, compared with glucose, acute consumption of fructose leads to increased postprandial energy expenditure and carbohydrate oxidation and decreased postprandial fat oxidation. The objective of this study was to determine the potential effects of increased fructose consumption compared to isocaloric glucose consumption on substrate utilization and energy expenditure following sustained consumption and under energy-balanced conditions.</p></sec><sec id="S2"><title>Subjects/Methods</title><p id="P2">As part of a parallel arm study, overweight/obese male and female subjects, 40&#x02013;72 y, consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 weeks. Energy expenditure and substrate utilization were assessed using indirect calorimetry at baseline and during the 10<sup>th</sup> week of intervention.</p></sec><sec id="S3"><title>Results</title><p id="P3">Consumption of fructose, but not glucose, led to significant decreases of net postprandial fat oxidation and significant increases of net postprandial carbohydrate oxidation (<italic>P</italic> &#x0003c; 0.0001 for both). Resting energy expenditure decreased significantly from baseline values in subjects consuming fructose (<italic>P</italic> = 0.031) but not in those consuming glucose.</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">Increased consumption of fructose for 10 weeks leads to marked changes of postprandial substrate utilization including a significant reduction of net fat oxidation. In addition, we report that resting energy expenditure is reduced compared to baseline values in subjects consuming fructose-sweetened beverages for 10 weeks.</p></sec></abstract><kwd-group><kwd>fructose</kwd><kwd>fat oxidation</kwd><kwd>carbohydrate oxidation</kwd><kwd>energy expenditure</kwd><kwd>metabolic rate</kwd><kwd>humans</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S5"><title>Introduction</title><p id="P5">An increase in the use of sweeteners containing fructose has occurred in parallel with the increasing prevalence of overweight and obesity over the past three decades in the U.S. (<xref rid="R3" ref-type="bibr">Bray et al 2004</xref>), suggesting that increased consumption of fructose, high fructose corn syrup, and/or sucrose may contribute to the current epidemic of obesity and the increased incidence of metabolic syndrome (<xref rid="R3" ref-type="bibr">Bray et al 2004</xref>, <xref rid="R8" ref-type="bibr">Havel 2005</xref>). In animal studies, consumption of diets high in fructose produces obesity, insulin resistance and dyslipidemia (<xref rid="R1" ref-type="bibr">Bezerra et al 2000</xref>, <xref rid="R6" ref-type="bibr">Elliott et al 2002</xref>, <xref rid="R8" ref-type="bibr">Havel 2005</xref>, <xref rid="R12" ref-type="bibr">Martinez et al 1994</xref>, <xref rid="R15" ref-type="bibr">Okazaki et al 1994</xref>, <xref rid="R21" ref-type="bibr">Storlien et al 1993</xref>). In humans, moderate fructose consumption has no apparent health concerns (Dolan et al 2010, Rizkalla 2010), but the health consequences of fructose consumption in large amounts are less clear, particularly its effects on substrate utilization and body weight regulation.</p><p id="P6">Recently we reported that consumption of fructose-sweetened beverages for 10 weeks, at 25% of energy requirements, increased hepatic <italic>de novo</italic> lipogenesis (DNL), promoted accumulation of intra-abdominal fat, produced a more atherogenic lipid profile, and reduced insulin sensitivity in older, overweight and obese adults compared with isocaloric consumption of glucose (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>). We hypothesized that the increased rate of DNL following consumption of fructose leads to an accumulation of hepatic lipid, which promotes dyslipidemia and decreases in insulin sensitivity (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>). McGarry observed that increases of DNL led to a concomitant reduction in fat oxidation, which may contribute to an accumulation of hepatic lipid (<xref rid="R14" ref-type="bibr">McGarry 1995</xref>). Therefore, to determine if the increases of DNL associated with increased fructose consumption were accompanied by decreased fat oxidation, we measured resting and postprandial substrate utilization and energy expenditure using indirect calorimetry in the overweight and obese adults during their participation in the study mentioned above (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>).</p><p id="P7">Previous investigations of the effects of fructose consumption on substrate utilization and energy expenditure are limited to acute or short-term studies (<xref rid="R4" ref-type="bibr">Chong et al 2007</xref>, <xref rid="R5" ref-type="bibr">Couchepin et al 2008</xref>, <xref rid="R11" ref-type="bibr">Markov et al 2000</xref>, <xref rid="R16" ref-type="bibr">Schwarz et al 1989</xref>, <xref rid="R17" ref-type="bibr">Schwarz et al 1992a</xref>, <xref rid="R18" ref-type="bibr">Schwarz et al 1992b</xref>, <xref rid="R22" ref-type="bibr">Tappy et al 1986</xref>). Our results from this 10 week study indicate that in overweight/obese adults, 40&#x02013;72 years of age, sustained consumption of fructose-sweetened beverages, at 25% of energy requirements, leads to decreased net postprandial fat oxidation and increased net postprandial carbohydrate oxidation, similar to what has been observed in short-term studies. In addition, we found that resting energy expenditure decreased significantly after 10 weeks in subjects consuming fructose-sweetened beverages, despite increases of body weight.</p></sec><sec sec-type="methods|subjects" id="S6"><title>Subjects and methods</title><sec id="S7"><title>Study design</title><p id="P8">This was a parallel arm study with 3 phases: 1) a 2-wk inpatient baseline period; 2) an 8-wk outpatient intervention period; and 3) a 2-wk inpatient intervention period. The details of the study design and diet interventions have been described (<xref rid="R20" ref-type="bibr">Stanhope, et al. 2009</xref>). Briefly, during baseline, subjects resided as inpatients and consumed an energy-balanced diet. Procedures included: indirect calorimetry, dual energy x-ray absorptiometry (DXA), and a computerized tomography (CT) scan of the abdomen. Subjects then began the 8-wk outpatient intervention and consumed either fructose- or glucose-sweetened beverages at 25% of energy requirements with self-selected <italic>ad libitum</italic> diets. Subjects returned as inpatients for the final 2 wks of intervention, during which the procedures were repeated while the subjects consumed their assigned glucose- or fructose-sweetened beverages as part of an energy-balanced diet.</p></sec><sec id="S8"><title>Subjects</title><p id="P9">Participants were recruited through advertisements and underwent a telephone and an in-person interview to assess eligibility. Inclusion criteria included age 40&#x02013;72 y, BMI 25&#x02013;35 kg/m<sup>2</sup>, and stable body weight during the prior six months. Women were post-menopausal. Exclusion criteria included: evidence of diabetes, renal or hepatic disease, fasting serum TG concentrations &#x0003e;400 mg/dL, blood pressure &#x0003e;140/90 mmHg, and surgery for weight loss. Individuals who smoked, reported exercise of more than 3.5 hrs/wk at a level more vigorous than walking, or having used thyroid, lipid-lowering, glucose-lowering, anti-hypertensive, anti-depressant, or weight loss medications were also excluded. Diet-related exclusion criteria included habitual ingestion of more than one sugar-sweetened beverage/d or more than two alcoholic beverages/d. The UC-Davis Institutional Review Board approved the study, and subjects provided informed consent to participate. Initially 39 subjects enrolled, but seven subjects did not complete the study due to personal or work-related conflicts, and one subject was opted out of the indirect calorimetry protocol. Thus, a total of 31 subjects completed the study: n=15 for the glucose group and n=16 for the fructose group. As previously reported (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>), baseline characteristics between the two experimental sugar groups were not different (<xref rid="T1" ref-type="table">Table 1</xref>).</p></sec><sec id="S9"><title>Diets</title><p id="P10">During the inpatient metabolic phases, subjects consumed diets designed to maintain energy balance providing 15% of energy as protein, 30% as fat, and 55% as carbohydrate. Daily energy intake was calculated at baseline using the Mifflin equation to estimate resting energy expenditure (REE) (Mifflin et al 1990) and adjusted for activity using a multiplication factor of 1.5. During baseline, the carbohydrate content consisted primarily of complex carbohydrates and contained 8.8 &#x000b1; 1.2 g of dietary fiber/1000 kcal. For the final 2-wk inpatient intervention period, subjects consumed diets at the baseline energy level and macronutrient composition except that 30% of energy was from complex carbohydrates and 25% was provided by fructose- or glucose-sweetened beverages. Additional details about the diet intake for inpatient and outpatient phases have been described previously (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>).</p></sec><sec id="S10"><title>Indirect calorimetry</title><p id="P11">An automated metabolic measuring cart (Truemax 2400 Metabolic Measurement System, Parvomedics, Salt Lake City, UT) was used to measure rates of O<sub>2</sub> consumption (VO<sub>2</sub>) and CO<sub>2</sub> production (VCO<sub>2</sub>). Gas analyzers were calibrated using a certified gas mixture of known O<sub>2</sub> and CO<sub>2</sub> concentrations, and the flowmeter was calibrated using a 3 L syringe, 4 times daily (07:00h, 11:00h, 15:00h, and 18:00h). The protocol was conducted at the CCRC at baseline-wk 0, and at intervention-wk 10 and was preceded by a minimum of 5 days of controlled diet. REE was measured on two separate days during wk 0 and again at wk 10, whereas postprandial energy expenditure (PPEE) was measured only once during wk 0 and once during wk 10, following a REE measurement. Respiratory gases were collected while subjects were in a semi-reclined position and wore a facemask fitted securely, covering the nose and mouth. The facemask was attached to tubing connected to the cart&#x02019;s mixing chamber. Through the facemask, subjects inhaled room air, and all expired breath was trapped by the mask and directed to the cart&#x02019;s mixing chamber for volume and gas analyses. Prior to the test, subjects fasted overnight for 13.5 h and rested quietly for at least 10 min before measurements commenced. REE was measured at 07:30 h and 08:30 h for 20 min periods. For PPEE, respiratory gases were collected for 15 min every hour over the next 14 h; the most stable 10-min interval of each 15-min collection was selected to represent PPEE for that hour. During the protocol subjects consumed the controlled breakfast (09:00 h), lunch (13:00 h), and dinner (18:00 h) meals. They were permitted to perform light activities associated with living in a metabolic ward, but rested in a semi-reclined position for at least 5 min before each measurement. Indirect calorimetry data were analyzed for all 31 subjects for REE, but only for 30 subjects for PPEE (n=15 in the fructose group and n=15 in the glucose group) due to procedure scheduling conflicts for one female in the fructose group.</p></sec><sec id="S11"><title>Calculation of energy expenditure and substrate oxidation rates</title><p id="P12">Energy expenditure was calculated using the Weir equation (<xref rid="R23" ref-type="bibr">Weir 1990</xref>): 
<disp-formula id="FD1"><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:mtext>Kcal</mml:mtext><mml:mo>/</mml:mo><mml:mo>min</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>3.941</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:msub><mml:mrow><mml:mrow><mml:mtext>VO</mml:mtext></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1.106</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:msub><mml:mrow><mml:mrow><mml:mtext>VCO</mml:mtext></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>2.17</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:mtext>urinary</mml:mtext><mml:mspace width="0.16667em"/><mml:mtext>N</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P13">Net carbohydrate oxidation (CHO-Ox) and net fat oxidation (FAT-Ox) were calculated using the following formulas (<xref rid="R7" ref-type="bibr">Frayn 1983</xref>): 
<disp-formula id="FD2"><mml:math id="M2" display="block" overflow="scroll"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mrow><mml:mtext>FAT</mml:mtext><mml:mo>&#x02212;</mml:mo><mml:mtext>Ox</mml:mtext><mml:mspace width="0.16667em"/></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>g</mml:mtext><mml:mo>/</mml:mo><mml:mo>min</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1.67</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:msub><mml:mrow><mml:mtext>VO</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1.67</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:msub><mml:mrow><mml:mtext>VCO</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1.92</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:mtext>urinary</mml:mtext><mml:mspace width="0.16667em"/><mml:mtext>N</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mtext>CHO</mml:mtext><mml:mo>&#x02212;</mml:mo><mml:mtext>Ox</mml:mtext><mml:mspace width="0.16667em"/></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>g</mml:mtext><mml:mo>/</mml:mo><mml:mo>min</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>4.55</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:msub><mml:mrow><mml:mtext>VCO</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>3.21</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:msub><mml:mrow><mml:mtext>VO</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>2.87</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:mtext>urinary</mml:mtext><mml:mspace width="0.16667em"/><mml:mtext>N</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p id="P14">For all equations, units for VO<sub>2</sub> and VCO<sub>2</sub> are in L/min. To estimate urinary nitrogen excretion, in g/min, a constant rate of protein catabolism was assumed, equivalent to the 24-h protein intake, as reported by Bingham (<xref rid="R2" ref-type="bibr">Bingham 2003</xref>).</p></sec><sec id="S12"><title>Measurements of body composition</title><p id="P15">Total body fat and fat free mass were determined by DXA, and intra- and extra-abdominal fat were measured by CT scan as described previously (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>).</p></sec><sec id="S13"><title>Data analysis</title><p id="P16">REE, PPEE and corresponding net substrate oxidation values for baseline and intervention were calculated using minute-by-minute values for VO<sub>2</sub> and VCO<sub>2</sub> (L/min). Overall PPEE and postprandial substrate oxidation rates were estimated by averaging values for the 14 postprandial time periods. Statistical tests were performed with SAS 9.2. The absolute or percent change for each outcome was analyzed in a 3-factor (type of sugar, gender, and + or &#x02212; metabolic syndrome) mixed procedure (PROC MIXED) ANOVA model with adjustment for the change in fat-free mass (FFM). The model was also run using baseline REE and PPEE as covariates, and the changes in REE and PPEE were still significant and comparable to those obtained when the model was adjusted for FFM. Metabolic syndrome (MetSyn) was defined as having at least 3 MetSyn risk factors as defined by the American Heart Association/National Heart Lung and Blood Institute (Grundy et al. 2004). There were nine subjects with MetSyn (Fructose n= 5, Glucose n = 4) and 22 subjects without MetSyn (Fructose n=11, Glucose n=11). Outcomes with least squares means (LS means) of the change (10 wk versus 0 wk) significantly different than zero were identified. Statistical tests with P values &#x0003c;0.05 were considered significant. Data are presented as mean &#x000b1; SEM.</p></sec></sec><sec sec-type="results" id="S14"><title>Results</title><sec id="S15"><title>Body weight and composition</title><p id="P17">As reported previously (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>), despite comparable weight gain (~1&#x02013;2% of initial body weight) following the 8-wk outpatient intervention, subjects consuming fructose primarily exhibited increases of visceral adipose tissue (VAT), while in subjects consuming glucose subcutaneous adipose tissue (SAT) was preferentially increased.</p></sec><sec id="S16"><title>Net substrate oxidation rates</title><p id="P18">Overall, fasting CHO-Ox did not change in response to glucose (<italic>P</italic> = 0.29) or fructose (<italic>P</italic> = 0.11) consumption, however subjects with metabolic syndrome consuming fructose exhibited significant increases of fasting CHO-Ox (<italic>P</italic> = 0.02) after 10 weeks of intervention (<xref rid="T2" ref-type="table">Table 2</xref>). Postprandial CHO-Ox increased significantly from baseline in subjects consuming fructose-sweetened beverages (<italic>P</italic> &#x0003c; 0.0001), but not in those consuming glucose-sweetened beverages (<italic>P</italic> = 0.54) (<xref rid="T2" ref-type="table">Table 2</xref>, <italic>P</italic><xref rid="F1" ref-type="fig">Figure 1</xref>). Similar to the fasting condition, subjects with metabolic syndrome consuming fructose exhibited marked percent increases of postprandial CHO-ox ( &#x0003c; 0.0001), whereas in subjects consuming fructose without metabolic syndrome postprandial CHO-ox rates were not changed from baseline values (<italic>P</italic> = 0.34) (sugar x MetSyn interaction: <italic>P</italic> = 0.01). There was also an effect of gender on the change of postprandial CHO-Ox (<italic>P</italic> = 0.05), such that male subjects in both sugar groups exhibited greater increases (21.35 &#x000b1; 9.8%; <italic>P</italic> &#x0003c; 0.001) than female subjects (5.75 &#x000b1; 3.9%; <italic>P</italic> = 0.81).</p><p id="P19">The change of fasting FAT-Ox differed both by sugar and by the presence/absence of MetSyn. While fasting FAT-Ox tended to decrease in the fructose group at 10 weeks (<italic>P</italic> = 0.15), this trend was driven by the larger decreases that were observed in subjects with metabolic syndrome (<italic>P</italic> = 0.14) as opposed to those without metabolic syndrome (P = 0.74). Although there was no overall change in fasting FAT-Ox in the glucose group at 10 weeks (<italic>P</italic> = 0.92), there was a significant decrease in subjects without metabolic syndrome (<italic>P</italic> &#x0003c; 0.05) (<xref rid="T2" ref-type="table">Table 2</xref>). In subjects consuming fructose-sweetened beverages postprandial FAT-Ox rates decreased significantly both compared with baseline values (P &#x0003c; 0.0001) and compared with subjects consuming glucose-sweetened beverages (P &#x0003c; 0.0001) (<xref rid="T2" ref-type="table">Table 2</xref>, <italic>P</italic><xref rid="F2" ref-type="fig">Figure 2</xref>). Overall the percent decrease of postprandial FAT-Ox was significant in subjects consuming fructose regardless of the presence ( &#x0003c; 0.0001) or absence (<italic>P</italic> = 0.0002) of MetSyn, whereas with glucose consumption only subjects without metabolic syndrome exhibited statistically significant decreases of postprandial FAT-Ox (<italic>P</italic> = 0.03) (<xref rid="T2" ref-type="table">Table 2</xref>).</p></sec><sec id="S17"><title>Energy expenditure</title><p id="P20">REE was significantly decreased from baseline values by wk 10 in subjects consuming fructose (<italic>P</italic> = 0.03) but not in those consuming glucose (<italic>P</italic> = 0.86). Postprandial energy expenditure also tended to decrease from baseline values in subjects in the fructose group but the change was not statistically significant (<italic>P</italic> = 0.19). PPEE was unchanged from baseline values in the glucose group (<italic>P =</italic> 0.86) (<xref rid="T3" ref-type="table">Table 3</xref>).</p></sec></sec><sec sec-type="discussion" id="S18"><title>Discussion</title><sec id="S19"><title>Net substrate oxidation rates</title><p id="P21">The results of acute and short-term studies of fructose ingestion, ranging from periods of 4 hours to 6 days, indicate that when fructose is consumed in large amounts ranging from 30&#x02013;50% of total calories, net fat oxidation is decreased and net carbohydrate oxidation is increased (<xref rid="R4" ref-type="bibr">Chong et al 2007</xref>, <xref rid="R5" ref-type="bibr">Couchepin et al 2008</xref>, <xref rid="R11" ref-type="bibr">Markov et al 2000</xref>, <xref rid="R16" ref-type="bibr">Schwarz et al 1989</xref>, <xref rid="R17" ref-type="bibr">Schwarz et al 1992a</xref>, <xref rid="R18" ref-type="bibr">Schwarz et al 1992b</xref>, <xref rid="R22" ref-type="bibr">Tappy et al 1986</xref>). However, the majority of these studies only examined the effects of consuming a single meal containing fructose, and those that examined the effects of multiple days of fructose consumption did not do so under energy-balanced conditions, but rather during consumption of 25&#x02013;50% excess calories. Importantly, our results demonstrate that the acute effects of fructose consumption persist when fructose is consumed over longer periods (10 wks), and in subjects consuming an energy-balanced diet, suggesting that fructose-induced changes of the regulation of key metabolic pathways involved in cellular energy utilization are sustained even in the absence of positive energy balance.</p><p id="P22">We have previously reported that sustained consumption of fructose-sweetened beverages increased hepatic DNL in these same subjects (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>). Schwarz et al reported strong correlations between changes of substrate oxidation rates (increased CHO-ox and decreased FAT-ox) and increases of DNL in subjects consuming 25% or 50% excess energy as carbohydrate (carbohydrate composition not specified) for 5 days (<xref rid="R19" ref-type="bibr">Schwarz et al 1995</xref>). Here we demonstrate that, under energy-balanced conditions, consuming 25% of energy from fructose leads to reduced net fat oxidation and increased net carbohydrate oxidation, in addition to previously reported increases of DNL (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>). This relationship was not observed with isocaloric glucose consumption suggesting that consumption of fructose, not carbohydrate in general (in this case monosaccharides), leads to these changes in the regulation of substrate oxidation and DNL; however recent evidence suggests that other factors such as differences in the amylose/amylopectin ratio of carbohydrate rich foods may also lead to similar changes (<xref rid="R9" ref-type="bibr">Isken et al 2010</xref>).</p><p id="P23">These findings support our hypothesis that decreases of fat oxidation occurring concurrently with fructose-induced upregulation of DNL promotes increases of hepatic lipid content, which may mediate the adverse changes in lipid metabolism and decreased insulin sensitivity we have reported previously (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>). These results are also consistent with the mechanism proposed by McGarry and others by which consumption of fructose leads to reductions of fat oxidation and increased carbohydrate oxidation (<xref rid="F3" ref-type="fig">Figure 3</xref>) (<xref rid="R13" ref-type="bibr">Mayes 1993</xref>) (<xref rid="R14" ref-type="bibr">McGarry 1995</xref>). It must be emphasized that values for substrate utilization derived from indirect calorimetry represent rates of substrate disappearance that may not always equate with rates of substrate oxidation. Determination of actual rates of substrate oxidation would require additional studies using isotopic tracer methodology.</p></sec><sec id="S20"><title>Effects of metabolic syndrome</title><p id="P24">We observed that subjects with metabolic syndrome consuming fructose-sweetened beverages exhibited the largest decreases of postprandial fat oxidation rates and increases of carbohydrate oxidation rates (<xref rid="T2" ref-type="table">Table 2</xref>). This relationship was not evident in subjects consuming glucose. It should be noted that the number of subjects entering the study with metabolic syndrome was small, 5 in the fructose group and 4 in the glucose group. Additionally, as we have reported previously (<xref rid="R20" ref-type="bibr">Stanhope et al 2009</xref>), 10 weeks of fructose consumption promoted the development of risk factors for MetSyn, such as accumulation of intra-abdominal fat, dyslipidemia and insulin resistance. Hence, it is likely that we are observing a worsening of metabolic function in subjects consuming fructose that is further exacerbated in those who already had evidence of MetSyn prior to the intervention.</p></sec><sec id="S21"><title>Effects of gender</title><p id="P25">We also observed that men consuming both glucose- and fructose-sweetened beverages exhibited greater increases of postprandial carbohydrate oxidation than women. These findings support those of Couchepin et al. who reported a significant increase of carbohydrate oxidation in male, but not female subjects consuming fructose (<xref rid="R5" ref-type="bibr">Couchepin et al 2008</xref>). Together these findings suggest that there is a gender-specific response with respect to changes of substrate utilization following sustained consumption of fructose.</p></sec><sec id="S22"><title>Energy expenditure</title><p id="P26">The decrease of REE that we observed in subjects consuming fructose was unexpected and conflicts with the findings of several previous short-term studies that reported increased energy expenditure following administration of oral fructose as compared with consumption of glucose (<xref rid="R16" ref-type="bibr">Schwarz et al 1989</xref>, <xref rid="R17" ref-type="bibr">Schwarz et al 1992a</xref>, <xref rid="R18" ref-type="bibr">Schwarz et al 1992b</xref>, <xref rid="R22" ref-type="bibr">Tappy et al 1986</xref>). These changes suggest that sustained fructose consumption may contribute to an overall reduction in energy expenditure, which could increase the risk for weight gain if energy intake is not adjusted downward accordingly. For example, if the mean measured decrease of REE associated with 10 weeks of fructose consumption, 0.09 kcal/min, was maintained for one year it could total ~15,000 kcals, assuming that REE reflects metabolism during rest/sleep periods adding to about 8 h/d; potentially, a gain of ~1.6 kg of body fat could result. Additional studies examining the effects of chronic sugar consumption on 24-hour energy expenditure conducted in a whole-room calorimeter are needed to confirm these findings and determine if the observed reductions in metabolic rate are directly related to fructose or to sweetener (i.e. sucrose, high fructose corn syrup, etc.) consumption in general. We are currently performing such measurements.</p></sec><sec id="S23" sec-type="conclusions"><title>Conclusions</title><p id="P27">Consumption of fructose at 25% of energy requirements for 10 weeks, when compared with isocaloric consumption of glucose, leads to significant reductions of net postprandial fat oxidation and increases of net postprandial carbohydrate oxidation. Furthermore, the results of this study demonstrate that these changes are evident even when fructose is consumed under energy-balanced conditions. We also report that resting energy expenditure is reduced compared to baseline values in subjects consuming fructose-sweetened beverages for 10 weeks. These findings may thus have important implications with regard to long-term energy balance in individuals consistently consuming large amounts of dietary fructose.</p></sec></sec></body><back><ack id="S24"><p>The authors thank Marinelle Nu&#x000f1;ez, Brandi Bair, Rebecca Stewart, Sara Wuehler, Barbara Gale, Artem Dyachenko and Patrick Lam for their excellent technical support and Nicole Mullen and the nursing staff at CCRC for their dedicated nursing support. We also thank Janet Peerson for expert advice on the statistical analysis of the data.</p><p><bold>Sources of funding:</bold></p><p>This research was supported with funding from NIH grant R01HL-075675. The project also received support from the UC Davis Clinical and Translational Science Center (grant UL1 RR024146). Dr. Havel&#x02019;s laboratory also receives support from NIH grants HL-091333, AT-002599, AT-002993, and AT-003545 and the American Diabetes Association. N.L. Keim&#x02019;s research is supported by intramural USDA-ARS CRIS 5306-51530-019-00D.</p></ack><fn-group><fn id="FN2" fn-type="conflict"><p><bold>Conflict of interest</bold></p><p>None of the authors had any financial or personal conflicts of interest.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezerra</surname><given-names>RM</given-names></name><name><surname>Ueno</surname><given-names>M</given-names></name><name><surname>Silva</surname><given-names>MS</given-names></name><name><surname>Tavares</surname><given-names>DQ</given-names></name><name><surname>Carvalho</surname><given-names>CR</given-names></name><name><surname>Saad</surname><given-names>MJ</given-names></name></person-group><year>2000</year><article-title>A high fructose diet affects the early steps of insulin action in muscle and liver of rats</article-title><source>J Nutr</source><volume>130</volume><fpage>1531</fpage><lpage>1535</lpage><pub-id pub-id-type="pmid">10827205</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bingham</surname><given-names>SA</given-names></name></person-group><year>2003</year><article-title>Urine nitrogen as a biomarker for the validation of dietary protein intake</article-title><source>J Nutr</source><volume>133</volume><issue>Suppl 3</issue><fpage>921S</fpage><lpage>924S</lpage><pub-id pub-id-type="pmid">12612177</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Nielsen</surname><given-names>SJ</given-names></name><name><surname>Popkin</surname><given-names>BM</given-names></name></person-group><year>2004</year><article-title>Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity</article-title><source>Am J Clin Nutr</source><volume>79</volume><fpage>537</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">15051594</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>MF</given-names></name><name><surname>Fielding</surname><given-names>BA</given-names></name><name><surname>Frayn</surname><given-names>KN</given-names></name></person-group><year>2007</year><article-title>Mechanisms for the acute effect of fructose on postprandial lipemia</article-title><source>Am J Clin Nutr</source><volume>85</volume><fpage>1511</fpage><lpage>1520</lpage><pub-id pub-id-type="pmid">17556686</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couchepin</surname><given-names>C</given-names></name><name><surname>Le</surname><given-names>KA</given-names></name><name><surname>Bortolotti</surname><given-names>M</given-names></name><name><surname>da Encarnacao</surname><given-names>JA</given-names></name><name><surname>Oboni</surname><given-names>JB</given-names></name><name><surname>Tran</surname><given-names>C</given-names></name><etal/></person-group><year>2008</year><article-title>Markedly blunted metabolic effects of fructose in healthy young female subjects compared with male subjects</article-title><source>Diabetes Care</source><volume>31</volume><fpage>1254</fpage><lpage>1256</lpage><pub-id pub-id-type="pmid">18332156</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>SS</given-names></name><name><surname>Keim</surname><given-names>NL</given-names></name><name><surname>Stern</surname><given-names>JS</given-names></name><name><surname>Teff</surname><given-names>K</given-names></name><name><surname>Havel</surname><given-names>PJ</given-names></name></person-group><year>2002</year><article-title>Fructose, weight gain, and the insulin resistance syndrome</article-title><source>Am J Clin Nutr</source><volume>76</volume><fpage>911</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">12399260</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frayn</surname><given-names>KN</given-names></name></person-group><year>1983</year><article-title>Calculation of substrate oxidation rates in vivo from gaseous exchange</article-title><source>J Appl Physiol</source><volume>55</volume><fpage>628</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">6618956</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havel</surname><given-names>PJ</given-names></name></person-group><year>2005</year><article-title>Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism</article-title><source>Nutr Rev</source><volume>63</volume><fpage>133</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">15971409</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isken</surname><given-names>F</given-names></name><name><surname>Klaus</surname><given-names>S</given-names></name><name><surname>Petzke</surname><given-names>KJ</given-names></name><name><surname>Loddenkemper</surname><given-names>C</given-names></name><name><surname>Pfeiffer</surname><given-names>AF</given-names></name><name><surname>Weickert</surname><given-names>MO</given-names></name></person-group><year>2010</year><article-title>Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype</article-title><source>Am J Physiol Endocrinol Metab</source><volume>298</volume><fpage>E287</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">19934403</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locke</surname><given-names>GA</given-names></name><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Witmer</surname><given-names>MR</given-names></name><name><surname>Tamura</surname><given-names>JK</given-names></name><name><surname>Haque</surname><given-names>T</given-names></name><name><surname>Carney</surname><given-names>RF</given-names></name><etal/></person-group><year>2008</year><article-title>Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate</article-title><source>Arch Biochem Biophys</source><volume>475</volume><fpage>72</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">18455495</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markov</surname><given-names>AK</given-names></name><name><surname>Neely</surname><given-names>WA</given-names></name><name><surname>Didlake</surname><given-names>RH</given-names></name><name><surname>Terry</surname><given-names>J</given-names><suffix>3rd</suffix></name><name><surname>Causey</surname><given-names>A</given-names></name><name><surname>Lehan</surname><given-names>PH</given-names></name></person-group><year>2000</year><article-title>Metabolic responses to fructose-1,6-diphosphate in healthy subjects</article-title><source>Metabolism</source><volume>49</volume><fpage>698</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">10877192</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>FJ</given-names></name><name><surname>Rizza</surname><given-names>RA</given-names></name><name><surname>Romero</surname><given-names>JC</given-names></name></person-group><year>1994</year><article-title>High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs</article-title><source>Hypertension</source><volume>23</volume><fpage>456</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">8144215</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayes</surname><given-names>PA</given-names></name></person-group><year>1993</year><article-title>Intermediary metabolism of fructose</article-title><source>Am J Clin Nutr</source><volume>58</volume><fpage>754S</fpage><lpage>765S</lpage><pub-id pub-id-type="pmid">8213607</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGarry</surname><given-names>JD</given-names></name></person-group><year>1995</year><article-title>Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership</article-title><source>Biochem Soc Trans</source><volume>23</volume><fpage>481</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">8566378</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okazaki</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name><name><surname>Ichino</surname><given-names>K</given-names></name><name><surname>Nakayama</surname><given-names>S</given-names></name><name><surname>Oguchi</surname><given-names>K</given-names></name></person-group><year>1994</year><article-title>Correlation between plasma fibrinogen and serum lipids in rats with hyperlipidemia induced by cholesterol free-high fructose or high cholesterol diet</article-title><source>J Nutr Sci Vitaminol (Tokyo)</source><volume>40</volume><fpage>479</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">7891208</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>JM</given-names></name><name><surname>Schutz</surname><given-names>Y</given-names></name><name><surname>Froidevaux</surname><given-names>F</given-names></name><name><surname>Acheson</surname><given-names>KJ</given-names></name><name><surname>Jeanpretre</surname><given-names>N</given-names></name><name><surname>Schneider</surname><given-names>H</given-names></name><etal/></person-group><year>1989</year><article-title>Thermogenesis in men and women induced by fructose vs glucose added to a meal</article-title><source>Am J Clin Nutr</source><volume>49</volume><fpage>667</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">2648796</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>JM</given-names></name><name><surname>Acheson</surname><given-names>KJ</given-names></name><name><surname>Tappy</surname><given-names>L</given-names></name><name><surname>Piolino</surname><given-names>V</given-names></name><name><surname>Muller</surname><given-names>MJ</given-names></name><name><surname>Felber</surname><given-names>JP</given-names></name><etal/></person-group><year>1992a</year><article-title>Thermogenesis and fructose metabolism in humans</article-title><source>Am J Physiol</source><volume>262</volume><fpage>E591</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">1350420</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>JM</given-names></name><name><surname>Schutz</surname><given-names>Y</given-names></name><name><surname>Piolino</surname><given-names>V</given-names></name><name><surname>Schneider</surname><given-names>H</given-names></name><name><surname>Felber</surname><given-names>JP</given-names></name><name><surname>Jequier</surname><given-names>E</given-names></name></person-group><year>1992b</year><article-title>Thermogenesis in obese women: effect of fructose vs. glucose added to a meal</article-title><source>Am J Physiol</source><volume>262</volume><fpage>E394</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">1566826</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>JM</given-names></name><name><surname>Neese</surname><given-names>RA</given-names></name><name><surname>Turner</surname><given-names>S</given-names></name><name><surname>Dare</surname><given-names>D</given-names></name><name><surname>Hellerstein</surname><given-names>MK</given-names></name></person-group><year>1995</year><article-title>Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection</article-title><source>J Clin Invest</source><volume>96</volume><fpage>2735</fpage><lpage>2743</lpage><pub-id pub-id-type="pmid">8675642</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanhope</surname><given-names>KL</given-names></name><name><surname>Schwarz</surname><given-names>JM</given-names></name><name><surname>Keim</surname><given-names>NL</given-names></name><name><surname>Griffen</surname><given-names>SC</given-names></name><name><surname>Bremer</surname><given-names>AA</given-names></name><name><surname>Graham</surname><given-names>JL</given-names></name><etal/></person-group><year>2009</year><article-title>Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</article-title><source>J Clin Invest</source><volume>119</volume><fpage>1322</fpage><lpage>1334</lpage><pub-id pub-id-type="pmid">19381015</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storlien</surname><given-names>LH</given-names></name><name><surname>Oakes</surname><given-names>ND</given-names></name><name><surname>Pan</surname><given-names>DA</given-names></name><name><surname>Kusunoki</surname><given-names>M</given-names></name><name><surname>Jenkins</surname><given-names>AB</given-names></name></person-group><year>1993</year><article-title>Syndromes of insulin resistance in the rat. Inducement by diet and amelioration with benfluorex</article-title><source>Diabetes</source><volume>42</volume><fpage>457</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">8432416</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tappy</surname><given-names>L</given-names></name><name><surname>Randin</surname><given-names>JP</given-names></name><name><surname>Felber</surname><given-names>JP</given-names></name><name><surname>Chiolero</surname><given-names>R</given-names></name><name><surname>Simonson</surname><given-names>DC</given-names></name><name><surname>Jequier</surname><given-names>E</given-names></name><etal/></person-group><year>1986</year><article-title>Comparison of thermogenic effect of fructose and glucose in normal humans</article-title><source>Am J Physiol</source><volume>250</volume><fpage>E718</fpage><lpage>724</lpage><pub-id pub-id-type="pmid">3521319</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>JB</given-names></name></person-group><year>1990</year><article-title>New methods for calculating metabolic rate with special reference to protein metabolism. 1949</article-title><source>Nutrition</source><volume>6</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">2136000</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>JR</given-names></name><name><surname>Cooper</surname><given-names>RH</given-names></name></person-group><year>1980</year><article-title>Regulation of the citric acid cycle in mammalian systems</article-title><source>FEBS Lett</source><volume>117</volume><issue>Suppl</issue><fpage>K73</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">6998729</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Net carbohydrate oxidation rate (g/min) profiles over 15 hours for subjects consuming glucose- and fructose-sweetened beverages. Subjects consumed meals at 09:00, 13:00, and 18:00 as indicated. The first 2 data points represent resting values and the remaining 14 data points represent postprandial values. Data points represent the mean of 10-min measurements &#x000b1; SEM with n=31 (fructose group n=16; glucose group n=15) for resting values and n=30 (fructose group n=15; glucose group n=15) for postprandial values.</p></caption><graphic xlink:href="nihms314569f1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Net fat oxidation rate (g/min) profiles over 15 hours for subjects consuming glucose-and fructose sweetened beverages. Subjects consumed meals at 09:00, 13:00, and 18:00 as indicated. The first 2 data points represent resting values and the remaining 14 data points represent postprandial values. Data points represent the mean of 10-min measurements &#x000b1; SEM. with n=31 (fructose group n=16; glucose group n=15) for resting values and n=30 (fructose group n=15; glucose group n=15) for postprandial values.</p></caption><graphic xlink:href="nihms314569f2"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Proposed mechanisms contributing to observed changes of substrate utilization in subjects consuming fructose-sweetened beverages. In the liver fructose is phosphorylated by fructokinase (which is not regulated by cellular energy status) and largely bypasses phosphofructokinase (PFK), the enzyme catalyzing the rate-limiting step of glycolysis (which is subject to inhibition by ATP and citrate). Ultimately fructose enters the glycolytic pathway as glyceraldehyde-3-phosphate. Following a high-fructose meal, an unregulated flux of fructose (Frc) carbon upregulates carbohydrate metabolism in the liver (increased CHO-Ox), leading to an increased flux of acetyl CoA through the tricarboxylic acid (TCA) cycle and a concomitant increase in cellular energy status (increased ATP/ADP ratio and NADH/NAD<sup>+</sup> ratio). A high NADH/NAD<sup>+</sup> ratio in the mitochondria results in substrate inhibition of isocitrate dehydrogenase (ICD) in the TCA cycle, leading to increased export of citrate to the cytosol, activation of acetyl-CoA carboxylase (ACC), and increased production of malonyl-CoA, the precursor to fatty acid synthesis (DNL). Elevated cytosolic concentrations of malonyl-CoA inhibit the carnitine shuttle via carnitine palmitoyl transferase (CPT), leading to reduced entry of fatty acids (FAs) into the mitochondria, decreased fat oxidation. The elevation of cellular energy status following a high-fructose meal would also lead to reduced mitochondrial availability of the fixed pool of oxidized cofactors NAD<sup>+</sup> and FAD, which are required substrates for &#x003b2;-oxidation, also resulting in reduced fat oxidation (<xref rid="R10" ref-type="bibr">Locke et al 2008</xref>, <xref rid="R13" ref-type="bibr">Mayes 1993</xref>, <xref rid="R14" ref-type="bibr">McGarry 1995</xref>, <xref rid="R24" ref-type="bibr">Williamson and Cooper 1980</xref>).</p></caption><graphic xlink:href="nihms314569f3"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Subject Characteristics at Baseline<xref rid="TFN1" ref-type="table-fn">1</xref>,<xref rid="TFN2" ref-type="table-fn">2</xref></p></caption><table frame="hsides" rules="none"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th colspan="2" valign="bottom" align="center" rowspan="1">Glucose</th><th colspan="2" valign="bottom" align="center" rowspan="1">Fructose</th></tr><tr><th colspan="5" valign="bottom" align="left" rowspan="1">
<hr/></th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Parameter</th><th valign="bottom" align="center" rowspan="1" colspan="1">Male (n=7)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Female (n=8)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Male (n=9)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Female (n=7)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (yr)</td><td align="center" valign="top" rowspan="1" colspan="1">54 &#x000b1; 3</td><td align="center" valign="top" rowspan="1" colspan="1">56 &#x000b1; 2</td><td align="center" valign="top" rowspan="1" colspan="1">52 &#x000b1; 4</td><td align="center" valign="top" rowspan="1" colspan="1">53 &#x000b1; 3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Weight (kg)</td><td align="center" valign="top" rowspan="1" colspan="1">88.4 &#x000b1; 2.9</td><td align="center" valign="top" rowspan="1" colspan="1">84.0 &#x000b1; 4.5</td><td align="center" valign="top" rowspan="1" colspan="1">89.3 &#x000b1; 2.9</td><td align="center" valign="top" rowspan="1" colspan="1">80.5 &#x000b1; 4.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">29.3 &#x000b1; 1.1</td><td align="center" valign="top" rowspan="1" colspan="1">29.4 &#x000b1; 1.3</td><td align="center" valign="top" rowspan="1" colspan="1">28.4 &#x000b1; 0.7</td><td align="center" valign="top" rowspan="1" colspan="1">30.0 &#x000b1; 1.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body Fat (%)</td><td align="center" valign="top" rowspan="1" colspan="1">29.4 &#x000b1; 1.1</td><td align="center" valign="top" rowspan="1" colspan="1">43.2 &#x000b1; 1.5</td><td align="center" valign="top" rowspan="1" colspan="1">28.5 &#x000b1; 1.3</td><td align="center" valign="top" rowspan="1" colspan="1">40.5 &#x000b1; 2.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fat Free Mass (kg)</td><td align="center" valign="top" rowspan="1" colspan="1">63.3 &#x000b1; 1.4</td><td align="center" valign="top" rowspan="1" colspan="1">48.2 &#x000b1; 2.1</td><td align="center" valign="top" rowspan="1" colspan="1">64.8 &#x000b1; 2.0</td><td align="center" valign="top" rowspan="1" colspan="1">47.6 &#x000b1; 2.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Triglycerides (mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">148 &#x000b1; 31</td><td align="center" valign="top" rowspan="1" colspan="1">145 &#x000b1; 23</td><td align="center" valign="top" rowspan="1" colspan="1">131 &#x000b1; 21</td><td align="center" valign="top" rowspan="1" colspan="1">151 &#x000b1; 36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cholesterol (mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">179 &#x000b1; 14</td><td align="center" valign="top" rowspan="1" colspan="1">193 &#x000b1; 10</td><td align="center" valign="top" rowspan="1" colspan="1">176 &#x000b1; 6</td><td align="center" valign="top" rowspan="1" colspan="1">197 &#x000b1; 14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDL-cholesterol (mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">124 &#x000b1; 5</td><td align="center" valign="top" rowspan="1" colspan="1">123 &#x000b1; 11</td><td align="center" valign="top" rowspan="1" colspan="1">107 &#x000b1; 7</td><td align="center" valign="top" rowspan="1" colspan="1">125 &#x000b1; 10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Glucose (mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">89 &#x000b1; 2</td><td align="center" valign="top" rowspan="1" colspan="1">89 &#x000b1; 3</td><td align="center" valign="top" rowspan="1" colspan="1">88 &#x000b1; 1</td><td align="center" valign="top" rowspan="1" colspan="1">90 &#x000b1; 2</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>1</label><p>Values are means&#x000b1; SEM. Clinical chemistry values are fasting values. There were no significant differences between sugar &#x000d7; gender groups.</p></fn><fn id="TFN2"><label>2</label><p>Data were published previously (<xref rid="R20" ref-type="bibr">Stanhope, et al. 2009</xref>).</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>Table 2</label><caption><p>Net carbohydrate and fat oxidation rates and percent change after consumption of glucose- or fructose-sweetened beverages for 10 wks<xref rid="TFN3" ref-type="table-fn">1</xref></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Fructose</th><th align="center" valign="bottom" rowspan="1" colspan="1">Fructose</th><th align="center" valign="bottom" rowspan="1" colspan="1">Fructose</th><th align="center" valign="bottom" rowspan="1" colspan="1">Glucose</th><th align="center" valign="bottom" rowspan="1" colspan="1">Glucose</th><th align="center" valign="bottom" rowspan="1" colspan="1">Glucose</th><th align="center" valign="bottom" rowspan="1" colspan="1"><xref rid="TFN4" ref-type="table-fn">2</xref> sugar</th><th align="center" valign="bottom" rowspan="1" colspan="1"><xref rid="TFN4" ref-type="table-fn">2</xref> sugar x MetSyn</th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Sample</th><th align="center" valign="bottom" rowspan="1" colspan="1">Baseline</th><th align="center" valign="bottom" rowspan="1" colspan="1">Week 10</th><th align="center" valign="bottom" rowspan="1" colspan="1">% change</th><th align="center" valign="bottom" rowspan="1" colspan="1">Baseline</th><th align="center" valign="bottom" rowspan="1" colspan="1">Week 10</th><th align="center" valign="bottom" rowspan="1" colspan="1">% change</th><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td colspan="10" align="center" valign="top" rowspan="1"><bold><underline>Carbohydrate Oxidation Rate, g/min</underline></bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fasting</td><td align="center" valign="top" rowspan="1" colspan="1">All</td><td align="center" valign="top" rowspan="1" colspan="1">0.16 &#x000b1; 0.06</td><td align="center" valign="top" rowspan="1" colspan="1">0.17 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">14.8 &#x000b1; 17.6</td><td align="center" valign="top" rowspan="1" colspan="1">0.16 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.18 &#x000b1; 0.07</td><td align="center" valign="top" rowspan="1" colspan="1">23.6 &#x000b1; 11.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.745</td><td align="center" valign="top" rowspan="1" colspan="1">0.047</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fasting</td><td align="center" valign="top" rowspan="1" colspan="1">(&#x02212;)MetSyn</td><td align="center" valign="top" rowspan="1" colspan="1">0.16 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.15 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.2 &#x000b1; 8.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.16 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.20 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">30.4 &#x000b1; 14.7</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fasting</td><td align="center" valign="top" rowspan="1" colspan="1">(+)MetSyn</td><td align="center" valign="top" rowspan="1" colspan="1">0.17 &#x000b1; 0.04</td><td align="center" valign="top" rowspan="1" colspan="1">0.20 &#x000b1; 0.03</td><td align="center" valign="top" rowspan="1" colspan="1">52.0 &#x000b1; 52.9<xref rid="TFN5" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.14 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.14 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">5.2 &#x000b1; 13.9</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postprandial</td><td align="center" valign="top" rowspan="1" colspan="1">All</td><td align="center" valign="top" rowspan="1" colspan="1">0.24 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.29 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">23.5 &#x000b1; 8.6<xref rid="TFN7" ref-type="table-fn">***</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.25 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.26 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">3.8 &#x000b1; 3.3</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">0.012</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postprandial</td><td align="center" valign="top" rowspan="1" colspan="1">(&#x02212;)MetSyn</td><td align="center" valign="top" rowspan="1" colspan="1">0.26 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.28 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">11.9 &#x000b1; 4.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.25 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.26 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">5.2 &#x000b1; 4.2</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postprandial</td><td align="center" valign="top" rowspan="1" colspan="1">(+)MetSyn</td><td align="center" valign="top" rowspan="1" colspan="1">0.21 &#x000b1; 0.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.29 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">46.6 &#x000b1; 21.8<xref rid="TFN7" ref-type="table-fn">***</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.23 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.23 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.04 &#x000b1; 8.3</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="center" valign="top" rowspan="1"><bold><underline>Fat Oxidation Rate, g/min</underline></bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fasting</td><td align="center" valign="top" rowspan="1" colspan="1">All</td><td align="center" valign="top" rowspan="1" colspan="1">0.06 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;13.1 &#x000b1; 8.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.06 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;14.2 &#x000b1; 14.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.366</td><td align="center" valign="top" rowspan="1" colspan="1">0.037</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fasting</td><td align="center" valign="top" rowspan="1" colspan="1">(&#x02212;)MetSyn</td><td align="center" valign="top" rowspan="1" colspan="1">0.06 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;7.0 &#x000b1; 7.6</td><td align="center" valign="top" rowspan="1" colspan="1">0.06 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;26.7 &#x000b1; 15.5<xref rid="TFN5" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fasting</td><td align="center" valign="top" rowspan="1" colspan="1">(+)MetSyn</td><td align="center" valign="top" rowspan="1" colspan="1">0.06 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.04 &#x000b1; 0.03</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;26.5 &#x000b1; 19.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">20.3 &#x000b1; 27.4</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postprandial</td><td align="center" valign="top" rowspan="1" colspan="1">All</td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.03 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;38.2 &#x000b1; 4.8<xref rid="TFN7" ref-type="table-fn">***</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.04 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;8.6 &#x000b1; 6.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.020</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postprandial</td><td align="center" valign="top" rowspan="1" colspan="1">(&#x02212;)MetSyn</td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.03 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;33.7 &#x000b1; 4.3<xref rid="TFN7" ref-type="table-fn">***</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.05 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.04 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;14.1 &#x000b1; 7.4<xref rid="TFN5" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postprandial</td><td align="center" valign="top" rowspan="1" colspan="1">(+)MetSyn</td><td align="center" valign="top" rowspan="1" colspan="1">0.06 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.03 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;47.4 &#x000b1; 11.0<xref rid="TFN7" ref-type="table-fn">***</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.04 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.04 &#x000b1; 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">6.3 &#x000b1; 6.9</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>1</label><p>Values are Means &#x000b1; SEM. Abbreviations: MetSyn=metabolic syndrome: (&#x02212;) without; (+) with. Sample sizes in sugar x MetSyn groups are: fructose(&#x02212;)MetSyn, n=11 resting, n=10 postprandial; fructose(+)MetSyn, n=5; glucose(&#x02212;)MetSyn, n=11; glucose(+)MetSyn, n=4.</p></fn><fn id="TFN4"><label>2</label><p>PROC MIXED 3-factor ANOVA (sugar, gender, (+) or (&#x02212;) MetSyn) adjusted for change in fat-free mass.</p></fn><fn id="TFN5"><label>*</label><p><italic>P</italic> &#x0003c; 0.05</p></fn><fn id="TFN6"><label>**</label><p><italic>P</italic> &#x0003c; 0.01</p></fn><fn id="TFN7"><label>***</label><p><italic>P</italic> &#x0003c; 0.001 for changes significantly different from zero.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float" orientation="landscape"><label>Table 3</label><caption><p>Energy expenditure before and after consumption of glucose- or fructose-sweetened beverages for 10 weeks<xref rid="TFN8" ref-type="table-fn">1</xref></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">Fructose Baseline</th><th valign="bottom" align="center" rowspan="1" colspan="1">Fructose 10 wk</th><th valign="bottom" align="left" rowspan="1" colspan="1">Fructose change</th><th valign="bottom" align="center" rowspan="1" colspan="1">Glucose Baseline</th><th valign="bottom" align="center" rowspan="1" colspan="1">Glucose 10 wk</th><th valign="bottom" align="center" rowspan="1" colspan="1">Glucose change</th><th valign="bottom" align="center" rowspan="1" colspan="1">P-value for effect of sugar<xref rid="TFN9" ref-type="table-fn">2</xref></th></tr></thead><tbody><tr><td colspan="8" align="left" valign="top" rowspan="1"><bold><underline>Energy Expenditure (kcal/min)</underline></bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><xref rid="TFN9" ref-type="table-fn">2</xref> Resting</td><td align="center" valign="top" rowspan="1" colspan="1">1.19 &#x000b1; 0.06</td><td align="center" valign="top" rowspan="1" colspan="1">1.10 &#x000b1; 0.04</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.09 &#x000b1; 0.04<xref rid="TFN10" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.17 &#x000b1; 0.07</td><td align="center" valign="top" rowspan="1" colspan="1">1.15 &#x000b1; 0.05</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.02 &#x000b1; 0.04</td><td align="center" valign="top" rowspan="1" colspan="1">0.108</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postprandial</td><td align="center" valign="top" rowspan="1" colspan="1">1.41 &#x000b1; 0.06</td><td align="center" valign="top" rowspan="1" colspan="1">1.37 &#x000b1; 0.05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.05 &#x000b1; 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">1.40 &#x000b1; 0.06</td><td align="center" valign="top" rowspan="1" colspan="1">1.36 &#x000b1; 0.05</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.03 &#x000b1; 0.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.445</td></tr></tbody></table><table-wrap-foot><fn id="TFN8"><label>1</label><p>Values are Means &#x000b1; SEM. Fasting values are based on n=31 (fructose group n=16; glucose group n=15) and postprandial values are based on n=30 (fructose group n=15; glucose group n=15).</p></fn><fn id="TFN9"><label>2</label><p>PROC MIXED 3-way model (sugar, gender, sugar, gender, (+) or (&#x02212;) metabolic syndrome) adjusted for change in fat-free mass.</p></fn><fn id="TFN10"><label>*</label><p><italic>P</italic> &#x0003c; 0.05 for changes significantly different from zero.</p></fn></table-wrap-foot></table-wrap></floats-group></article>